Ohio Public Employees Retirement System (OPERS)’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,253
Closed -$35.8K 2020
2023
Q4
$35.8K Sell
5,253
-10,847
-67% -$62.7K ﹤0.01% 1663
2023
Q3
$88K Sell
16,100
-2,000
-11% -$11.6K ﹤0.01% 1446
2023
Q2
$123K Buy
+18,100
New +$136K ﹤0.01% 1430

Other funds holding YMAB

Ohio Public Employees Retirement System (OPERS)'s YMAB Position: Q1 2024 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Y-mAbs Therapeutics (YMAB) in Q1 2024, closing a stake of 5,253 shares — an estimated $35.8K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in YMAB in Q2 2023 and held it in 3 quarters. The position peaked at $123K in Q2 2023. 96 funds tracked by Wall St. Rank hold YMAB as of Q1 2024.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Y-mAbs Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 5,253 Y-mAbs Therapeutics shares in Q1 2024, an estimated $35.8K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Y-mAbs Therapeutics in Q2 2023 and held it in 3 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Y-mAbs Therapeutics position peaked at $123K in Q2 2023.
  • 96 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q1 2024.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2024, filed 15 May 2024.